CatalystWireBeta

UK small-cap RNS · 13 Apr 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies
  1. 13:35
    Holding(s) in Company Holding
  2. 07:00
    Alm. Brand Group Extends LeakBot Programme
    Brand Group offers LeakBot to 160,000 homeowners to prevent water damage
    Moved: Alm. Brand Group LeakBot rollout: Trial completed; full rollout committed → Extended to up to 160,000 homeowners
  3. 07:00
    Energean ENOG £1,358m
    Update on Restart of Production from the FPSO
    Confirms the Israel FPSO is fully operational and output is back to regular levels within 48 hours of the ministry's notice, ending the six-week suspension. Guidance impact is still unquantified.
    Upgrade / downgrade cycle +1.2% on the day
    Moved: Israel production disruptions: Restart permitted 9 April; ramp-up under way → FPSO fully operational; guidance update pending
  4. 07:00
    Total Resources at Mbe increased to 1.23m oz gold
    Total JORC Resources at Mbe increased to 1.23 million oz contained gold
    Project milestones outlook positive +10.3% on the day
    Moved: Mbe resource delineation and development: MB01-N drilling 46% complete; first two holes intersect gold → MB01-N resource published; MB01-S step-out drilling underway · BCM earn-in to 50% interests: Awaiting MB01-N programme completion, late Q1 2026 → BCM earned 50%; JV agreement being drafted
  5. 07:00
    Corporate Update
    The new MD's workstream review widens MCB funding to three streams and plans to replace Sodor with a new Filipino partner in MMCI, but pushes the FID out to Q4 2026.
    Disposal of a part (break-up) outlook mixed, loweredfirst since Oct 2023 +0.0% on the day
    Moved: MCB copper-gold project development: DFS done; new MD to finalise financing → Funding widened to three streams; FID extended to Q4 2026 · Sodor 60% MCB interest transfer: Conditions still outstanding; Celsius holds 40% → Dispute; new Filipino partner in advanced talks · new: Sale of Opuwo Project – Non-binding offers received; site visits done
  6. 07:00
    Pfizer Licensing Agreement Renewal
    Pfizer renews its licence for IBD patient-support content, confirming a repeat customer, but no value or term is given and the company's runway is still only into May 2026.
    Balance-sheet stress / refinancing outlook negative +25.0% on the day
    Moved: Cash runway and fundraising: Runway into late April; Alumni facility constrained → Runway extended into May 2026; funding unsecured
  7. 07:00
    Year End Trading Update Trading update
    FY26 revenue and adjusted EBITDA (£1.2m vs £0.2m in H1) came in ahead of market expectations after a weak H1, so the earlier 'stronger H2' guidance was beaten.
    Upgrade / downgrade cycle ahead of expectationsoutlook positive +14.8% on the day
    Moved: AI-enabled consultative MSP transition: Saxis bolt-on acquisition completed, cash funded → Saxis contributing; early AI benefits in Q4
  8. 07:00
    Trading Update Trading update
    Confirms full-year results in line with market expectations, with like-for-like rent roll growth accelerating in H2 and positive valuation movement expected, after the February raise and deal pipeline.
    Large acquisition / reverse takeover in lineoutlook positivefirst in 6 months −1.2% on the day
    Moved: German defence-related acquisitions: In exclusivity; funding secured → Kiel completed; second deal dropped; two replacements
  9. 07:00
    Final Results Results
    Full-year results confirm the January guidance: revenue up 14% to £45.9m and PBT up 25% to £6.5m, with the Board confident of FY26 in line with expectations of £52.0m revenue and £8.0m PBT.
    Segment turn £47.0m · 19% of mcapin lineoutlook positivefirst in 12 months −5.3% on the day
    Moved: Colchester facility relocation: Los Angeles operational; Colchester due H1 FY26 → Los Angeles complete; Colchester expansion described as completed · Defence prime design services contract: Expanded to $6.2m, largest single order → $6.2m programme, all 2025 milestones met · new: Systems unit path to profitability – FY25 performance below expectations; revenue up 157%
  10. 07:00
    Pre-close trading update Trading update
    FY26 adjusted EBITDA of about £1.25m is well below the £3.5m of last year, with sales down 22% after Boots ended and Middle East disruption; the Iran war cost about £0.1m.
    Balance-sheet stress / refinancing outlook mixedfirst since Oct 2023 −20.6% on the day
    Moved: Strategic discussions to restore UK scale: Talks with several interested parties ongoing → Talks with several parties continue · Debt facility covenant breach: Refinanced to Dec 2027; still in default, repayable on demand → No material change since February refinancing

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note